Literature DB >> 31508913

[Arterial hypertension and obstructive sleep apnea syndrome: state of knowledge].

Damiano Salmina1, Adam Ogna1, Grégoire Wuerzner2, Raphaël Heinzer3, Valentina Forni Ogna1,2.   

Abstract

Obstructive sleep apnea syndrome (OSAS) and arterial hypertension (HT) are two frequent, often concomitant diseases, who are both associated with an increased cardiovascular risk. In the last years, an association between these two entities has been established. The purpose of this article is to review the current knowledge about the link between HT and OSAS, the pathophysiological mechanisms involved in the common genesis of the two conditions and the characteristics suggesting an underlying OSAS in a hypertensive subject. We will also update readers about the current screening of OSAS in which primary care physicians are directly involved, and review the pros and cons of different treatment options for HT in OSAS.

Entities:  

Mesh:

Year:  2019        PMID: 31508913

Source DB:  PubMed          Journal:  Rev Med Suisse        ISSN: 1660-9379


  2 in total

1.  miR-485-5p alleviates obstructive sleep apnea syndrome with hypertension by inhibiting PI3K/AKT signaling pathway via downregulating HIF3A expression.

Authors:  Yan Xu; Tao Hu; Huizhen Ding; Yi Yuan; Rui Chen
Journal:  Sleep Breath       Date:  2022-02-08       Impact factor: 2.816

2.  Associations of the Severity of Obstructive Sleep Apnea With Age-Related Comorbidities: A Population-Based Study.

Authors:  Mayra Dos Santos Silva; Dalva Poyares; Luciana Oliveira Silva; Ksdy M Souza; Monica L Andersen; Maurice M Ohayon; Sergio Tufik; Ronaldo D Piovezan
Journal:  Front Neurol       Date:  2022-05-10       Impact factor: 4.086

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.